Overview
Location
United States, Pennsylvania, Philadelphia
Mentions in press and media 12
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 18, 2025 | HMP Global’s Drug Channels Institute releases ‘2025 Economic Report on U.S. Pharmacies and PBMs,’ examining $683B market | This report remains the most comprehensive, fact-based tool for understanding the entire U.S. drug pricing, reimbursement, and dispensing system. New report analyzes market trends, consolidation, and the evolving role of Pharmacy Benefit Ma... |
| Jun 24, 2024 | Cencora, Eli Lilly, Optum Rx, Walgreens executives to headline HMP Global’s inaugural Drug Channels Leadership Forum | The Drug Channels Leadership Forum will be held March 17-19, 2025, at Turnberry Resort and Spa in Miami. Its program focuses on the future of drug channels, featuring candid conversations with top leaders, innovators, and policymakers on ke... |
| Jun 11, 2024 | Health | An obscure drug discount program stifles use of federal lifeline by rural hospitals | Federal lawmakers have introduced a handful of legislative solutions since March. In one bill, senators from Kansas and Minnesota list a myriad of tactics, including allowing older closed facilities to reopen. Another proposal introduced in... |
| Mar 19, 2024 | HMP Global’s Drug Channels Institute releases ‘2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers’ | This year’s report updates all market and industry data with the most current information available, including DCI’s exclusive analyses of the market positions of the largest pharmacies, specialty pharmacies, and PBMs. Report: U.S. prescrip... |
| Mar 14, 2023 | New Drug Channels Institute Study Analyzes Impact of Inflation Reduction Act on U.S. Prescription Market | The 2023 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers Beginning this year, the Inflation Reduction Act of 2022 (IRA) will alter many crucial aspects of the Medicare Part D program and the overall drug channel. PHILADELPH... |
| Oct 11, 2022 | New Drug Channels Institute Study: U.S. Drug Distribution Industry Expands as COVID-19 Disruption Fades and Biosimilars Boom | The 2022–23 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors The Inflation Reduction Act of 2022 will trigger multiple changes in pharmacy and provider markets that will negatively impact wholesalers, although wholes... |
| May 18, 2022 | PhRMA's court win over HHS could be a boon for pharma patient assistance programs | As out-of-pocket costs have risen for patients in the US in recent years, pharma manufacturers have offered financial assistance — including to those with commercial insurance — to better shoulder these higher costs. C... |
| Mar 15, 2022 | New Drug Channels Institute Study Examines Consolidation and Vertical Integration of U.S. Prescription Market | 2022 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers For 2021, more than 80% of all equivalent prescription claims were processed by three companies: CVS Health (including Caremark and Aetna); the Express Scripts business o... |
| Mar 16, 2021 | New Drug Channels Institute Study: The Latest Trends for U.S. Drug Pricing, Reimbursement, and Patient Costs | Total prescription dispensing revenues of retail, mail, long-term care, and specialty pharmacies reached a record $465 billion in 2020. Specialty drugs accounted for nearly 40% of these revenues—and an even greater share of payers’ net pres... |
Show more
Reviews 0
FAQ about Drug Channels Institute
What has the press written about Drug Channels Institute?
Parsers VC has collected 12 articles mentioning Drug Channels Institute, among them “HMP Global’s Drug Channels Institute releases ‘2025 Economic Report on U.S. Pharmacies and PBMs,’ examining $683B market” (Mar 18, 2025) and “Cencora, Eli Lilly, Optum Rx, Walgreens executives to headline HMP Global’s inaugural Drug Channels Leadership Forum” (Jun 24, 2024).
Is Drug Channels Institute still active?
Yes, Drug Channels Institute is active; its latest activity on Parsers VC dates from Aug 1, 2026.